Business Description

Description
IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.16
9-Day RSI 2.84
14-Day RSI 11.71
6-1 Month Momentum % -99.93
12-1 Month Momentum % -100

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-EBIT -0.2
EV-to-Forward-EBITDA -0.2
EV-to-Forward-Revenue 16.44

Financials (Next Earnings Date:2024-05-15 Est.)

IMVIQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IMVIQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

IMV Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.55
Beta -0.31
Volatility % 155.06
14-Day RSI 11.71
14-Day ATR ($) 0.000053
20-Day SMA ($) 0.00001
12-1 Month Momentum % -100
52-Week Range ($) 0.00001 - 1
Shares Outstanding (Mil) 11.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IMV Inc Filings

Filing Date Document Date Form
No Filing Data

IMV Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

IMV Inc Frequently Asked Questions

What is IMV Inc(IMVIQ)'s stock price today?
The current price of IMVIQ is $0.00. The 52 week high of IMVIQ is $1.00 and 52 week low is $0.00.
When is next earnings date of IMV Inc(IMVIQ)?
The next earnings date of IMV Inc(IMVIQ) is 2024-05-15 Est..
Does IMV Inc(IMVIQ) pay dividends? If so, how much?
IMV Inc(IMVIQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1